CardioWrap is indicated for use as a pericardium replacement device in patients that may require re-operation within six months.
Almost all medical devices and products must go through clinical studies and regulatory reviews before they are commercially released, with different countries having different requirements before a product is approved for market. In this section, we have included a number of products that are available in certain countries and not yet available in the United States.